Combined Pharmacologic/Nonpharmacologic Intervention in Individuals at High Risk of Developing Type 2 Diabetes: Pro pharmacologic therapy

por Garber, Alan J.
Publicado 2009

Incretin Effects on β-Cell Function, Replication, and Mass: The human perspective

por Garber, Alan J.
Publicado 2011

Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A review of their efficacy and tolerability

por Garber, Alan J.
Publicado 2011

The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone

por DeFronzo, Ralph A., Hissa, Miguel N., Garber, Alan J., Luiz Gross, Jorge, Yuyan Duan, Raina, Ravichandran, Shoba, Chen, Roland S.
Publicado 2009

Efficacy and Safety of Switching From the DPP-4 Inhibitor Sitagliptin to the Human GLP-1 Analog Liraglutide After 52 Weeks in Metformin-Treated Patients With Type 2 Diabetes: A ran...

por Pratley, Richard E., Nauck, Michael A., Bailey, Timothy, Montanya, Eduard, Filetti, Sebastiano, Garber, Alan J., Thomsen, Anne B., Furber, Sabina, Davies, Melanie
Publicado 2012